← back to search

David D. Hurd

Dana-Farber Cancer Institute · US
Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation, and Multiple Myeloma Research and Treatments.
h-index
44
citations
10,264
works
237
NIH funding
primary concept
Medicine
email

Recent publications

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
New England Journal of Medicine 2022cited by 451position: middledoi
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: <scp>CALGB</scp>/Alliance 50403
American Journal of Hematology 2020cited by 20position: middledoi
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
The Lancet Haematology 2017cited by 168position: middledoi
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)
Investigational New Drugs 2013cited by 21position: middledoi
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
New England Journal of Medicine 2012cited by 1,140position: middledoi

Grants

Collaborative Research: GP-IN: GLOBE Weather Pathways for Students with Disabilities
NSF2229352$41,5632022–2025PIRePORTER
The Effects of Skeletal Microstructure on the Preservation And Rate of Recycling of Biogenic Silica in the Oceans
NSF7925412$30,0001980–1981PIRePORTER
Intercalibration and Critical Examination of Biogenic SilicaAnalytics
NSF7720446$49,4001978–1979PIRePORTER
The Study of Specific Surface Area and Skeletal Porosity As Controlling Parameters in Coral and Reef Calcification
NSF7808697$20,0001978–1979PIRePORTER

Frequent collaborators

John C. Byrd · The University of Texas Southwestern Medical Center1 papers (2020–2020)Wendy Stock · Leukemia Research Foundation1 papers (2020–2020)David W. Scott · BC Cancer Agency1 papers (2020–2020)Ravi Vij · Columbia University1 papers (2013–2013)Eric D. Hsi · Mayo Clinic1 papers (2020–2020)Robert P. Hasserjian · Harvard University1 papers (2013–2013)Kouros Owzar · Duke University1 papers (2013–2013)John P. Leonard · NYU Langone Health1 papers (2020–2020)Pankaj Gupta · University of Minnesota, Twin Cities1 papers (2013–2013) · 1 papers (2013–2013)Ben L. Sanford · Duke Cancer Institute1 papers (2013–2013)Kristie A. Blum · Winship Cancer Institute1 papers (2020–2020)Matthew J. Maurer · Toyota Motor Corporation (Switzerland)1 papers (2020–2020)Olatoyosi Odenike · Leipzig University1 papers (2013–2013)Lawrence D. Kaplan · University of Southern California1 papers (2020–2020)Clara D. Bloomfield · The Ohio State University1 papers (2013–2013)Francisco J. Hernandez‐Ilizaliturri · Roswell Park Comprehensive Cancer Center1 papers (2020–2020)Richard M. Stone · Harvard University1 papers (2013–2013)Nancy L. Bartlett · City of Hope1 papers (2020–2020)Bruce D. Cheson · Center for Cancer and Blood Disorders1 papers (2020–2020)